Lack of Association of XRCC4 (rs1805377) and ATF6 (rs2070150) SNPs with HCC in Thai Patients with HBV Infection
暂无分享,去创建一个
N. Chuaypen | P. Tangkijvanich | J. Makkoch | K. Praianantathavorn | S. Payungporn | Watanyoo Sopipong
[1] Kun Li,et al. Association of Genetic Polymorphisms in PRKDC and XRCC4 with Risk of ESCC in a High-Incidence Region of North China , 2016, Tumori.
[2] Yibing Chen,et al. SNP rs2057482 in HIF1A gene predicts clinical outcome of aggressive hepatocellular carcinoma patients after surgery , 2015, Scientific Reports.
[3] S. Zhang,et al. Significance of genetic variants in DLC1 and their association with hepatocellular carcinoma , 2015, Molecular medicine reports.
[4] S. Qi,et al. Association of LIG4 and XRCC4 gene polymorphisms with the risk of human glioma in a Chinese population. , 2015, International journal of clinical and experimental pathology.
[5] N. Rothman,et al. Polymorphisms in DNA repair genes, hair dye use, and the risk of non-Hodgkin lymphoma , 2014, Cancer Causes & Control.
[6] Y. Liu,et al. A missense polymorphism in ATF6 gene is associated with susceptibility to hepatocellular carcinoma probably by altering ATF6 level , 2014, International journal of cancer.
[7] G. Cao,et al. Interaction of signal transducer and activator of transcription 3 polymorphisms with hepatitis B virus mutations in hepatocellular carcinoma , 2013, Hepatology.
[8] P. Tangkijvanich,et al. The KIF1B (rs17401966) single nucleotide polymorphism is not associated with the development of HBV-related hepatocellular carcinoma in Thai patients. , 2013, Asian Pacific journal of cancer prevention : APJCP.
[9] Lin Zhao,et al. Genetic polymorphisms of DNA double-strand break repair pathway genes and glioma susceptibility , 2013, BMC Cancer.
[10] H. M. Reis,et al. Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma , 2013, Nature Reviews Cancer.
[11] Qiang Ding,et al. Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus–related hepatocellular carcinoma , 2012, Nature Genetics.
[12] G. Sethi,et al. Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma. , 2013, Biochimica et biophysica acta.
[13] H. Chung,et al. Annals of the New York Academy of Sciences Unfolded Protein Response to Autophagy as a Promising Druggable Target for Anticancer Therapy , 2022 .
[14] Pål Sætrom,et al. Single Nucleotide Polymorphisms Can Create Alternative Polyadenylation Signals and Affect Gene Expression through Loss of MicroRNA-Regulation , 2012, PLoS Comput. Biol..
[15] R. Mandal,et al. Do polymorphisms in XRCC4 influence prostate cancer susceptibility in North Indian population? , 2011, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[16] F. Zoulim,et al. Hepatitis B virus induced hepatocellular carcinoma. , 2009, Cancer letters.
[17] H. Hsu,et al. Lung cancer susceptibility and prognosis associated with polymorphisms in the nonhomologous end‐joining pathway genes , 2009, Cancer.
[18] T. Liang. Hepatitis B: The virus and disease , 2009, Hepatology.
[19] Jin-Lin Hou,et al. Hepatocellular carcinoma in the Asia pacific region , 2009, Journal of gastroenterology and hepatology.
[20] P. Walter,et al. The unfolded protein response during prostate cancer development , 2009, Cancer and Metastasis Reviews.
[21] Hushan Yang,et al. Genetic Susceptibility to Renal Cell Carcinoma: The Role of DNA Double-Strand Break Repair Pathway , 2008, Cancer Epidemiology Biomarkers & Prevention.
[22] M. Tsai,et al. Association of XRCC4 codon 247 polymorphism with oral cancer susceptibility in Taiwan. , 2008, Anticancer research.
[23] M. Tsai,et al. A novel single nucleotide polymorphism in XRCC4 gene is associated with oral cancer susceptibility in Taiwanese patients. , 2008, Oral oncology.
[24] Debra Silverman,et al. Evaluation of genetic variation in the double-strand break repair pathway and bladder cancer risk. , 2007, Carcinogenesis.
[25] P. Galle,et al. Hepatitis viruses: live and let die , 2007, Liver international : official journal of the International Association for the Study of the Liver.
[26] C. Koumenis,et al. The PERK/eIF2alpha/ATF4 module of the UPR in hypoxia resistance and tumor growth. , 2006, Cancer biology & therapy.
[27] H. Blum,et al. Hepatocellular carcinoma: therapy and prevention. , 2005, World journal of gastroenterology.
[28] D. Ganem,et al. Hepatitis B virus infection--natural history and clinical consequences. , 2004, The New England journal of medicine.
[29] S. Kaneko,et al. Mechanisms of viral hepatitis induced liver injury. , 2003, Current molecular medicine.
[30] Chen-Yang Shen,et al. Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: a multigenic study on cancer susceptibility. , 2003, Cancer research.
[31] K. Mori,et al. Activation of the ATF6, XBP1 and grp78 genes in human hepatocellular carcinoma: a possible involvement of the ER stress pathway in hepatocarcinogenesis. , 2003, Journal of hepatology.
[32] Chien-Jen Chen,et al. Interaction of hepatitis B virus, chemical carcinogen, and genetic susceptibility: Multistage hepatocarcinogenesis with multifactorial etiology , 2002, Hepatology.
[33] J. Higginson,et al. International Agency for Research on Cancer. , 1968, WHO chronicle.